After years of debate and discussion, the public-private National Evaluation System for health Technology (NEST), which FDA officials have said will re-make device data collection in the US, is finally getting off the ground. Leading the endeavor is Rachael Fleurence, who took on the role of executive director of NEST's Coordinating Center last month.
Over the next year, Fleurence will work with stakeholders to develop a NEST five-year plan and begin hiring staff to...